|
1
|
Charlton J, Pavasovic V and
Pritchard-Jones K: Biomarkers to detect Wilms tumors in pediatric
patients: Where are we now? Future Oncol. 11:2221–2234. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cone EB, Dalton SS, Van Noord M, Tracy ET,
Rice HE and Routh JC: Biomarkers for Wilms tumor: A systematic
review. J Urol. 196:1530–1535. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Qi C, Hu Y, Yang F, An H, Zhang J, Jin H
and Guo F: Preliminary observations regarding the expression of
collagen triple helix repeat-containing 1 is an independent
prognostic factor for Wilms' tumor. J Pediatr Surg. 51:1501–1506.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brok J, Pritchard-Jones K, Geller JI and
Spreafico F: Review of phase I and II trials for Wilms' tumour-Can
we optimise the search for novel agents? Eur J Cancer. 79:205–213.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yu X, Li Z, Chan MT and Wu WK: The roles
of microRNAs in Wilms' tumors. Tumour Biol. 37:1445–1450. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li X, Liu F, Lin B, Luo H, Liu M, Wu J, Li
C, Li R, Zhang X, Zhou K and Ren D: miR-150 inhibits proliferation
and tumorigenicity via retarding G1/S phase transition in
nasopharyngeal carcinoma. Int J Oncol. 50:1097–1108. 2017.
View Article : Google Scholar
|
|
7
|
Ro S, Park C, Young D, Sanders KM and Yan
W: Tissue-dependent paired expression of miRNAs. Nucleic Acids Res.
35:5944–5953. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mallory AC and Vaucheret H: MicroRNAs:
Something important between the genes. Curr Opin Plant Biol.
7:120–125. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ebert MS and Sharp PA: Roles for microRNAs
in conferring robustness to biological processes. Cell.
149:515–524. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rogers K and Chen X: Biogenesis, turnover,
and mode of action of plant microRNAs. Plant Cell. 25:2383–2399.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hayes J, Peruzzi PP and Lawler S:
MicroRNAs in cancer: Biomarkers, functions and therapy. Trends Mol
Med. 20:460–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xiao ZQ, Yin TK, Li YX, Zhang JH and Gu
JJ: miR-130b regulates the proliferation, invasion and apoptosis of
glioma cells via targeting of CYLD. Oncol Rep. 38:167–174. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun B, Li L, Ma W, Wang S and Huang C:
MiR-130b inhibits proliferation and induces apoptosis of gastric
cancer cells via CYLD. Tumour Biol. 37:7981–7987. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li BL, Lu C, Lu W, Yang TT, Qu J, Hong X
and Wan XP: miR-130b is an EMT-related microRNA that targets DICER1
for aggression in endometrial cancer. Med Oncol. 30:4842013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Di Cristofano A and Pandolfi PP: The
multiple roles of PTEN in tumor suppression. Cell. 100:387–390.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zheng L, Zhang Y, Liu Y, Zhou M, Lu Y,
Yuan L, Zhang C, Hong M, Wang S and Li X: MiR-106b induces cell
radioresistance via the PTEN/PI3K/Akt pathways and p21 in
colorectal cancer. J Transl Med. 13:2522015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou X, Yang X, Sun X, Xu X, Li X, Guo Y,
Wang J, Li X, Yao L, Wang H and Shen L: Effect of PTEN loss on
metabolic reprogramming in prostate cancer cells. Oncol Lett.
17:2856–2866. 2019.PubMed/NCBI
|
|
20
|
Shin VY and Chu KM: MiRNA as potential
biomarkers and therapeutic targets for gastric cancer. World J
Gastroenterol. 20:10432–10439. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rocci A, Hofmeister CC and Pichiorri F:
The potential of miRNAs as biomarkers for multiple myeloma. Expert
Rev Mol Diagn. 14:947–959. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Galardi A, Colletti M, Businaro P,
Quintarelli C, Locatelli F and Di Giannatale A: MicroRNAs in
neuroblastoma: Biomarkers with therapeutic potential. Curr Med
Chem. 25:584–600. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yuan Y, Anbalagan D, Lee LH, Samy RP,
Shanmugam MK, Kumar AP, Sethi G, Lobie PE and Lim LH: ANXA1
inhibits miRNA-196a in a negative feedback loop through NF-κB and
c-Myc to reduce breast cancer proliferation. Oncotarget.
7:27007–27020. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang L, Li Q, Wang Q, Jiang Z and Zhang L:
Silencing of miRNA-218 promotes migration and invasion of breast
cancer via Slit2-Robo1 pathway. Biomed Pharmacother. 66:535–540.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li P, Xie XB, Chen Q, Pang GL, Luo W, Tu
JC, Zheng F, Liu SM, Han L, Zhang JK, et al: MiRNA-15a mediates
cell cycle arrest and potentiates apoptosis in breast cancer cells
by targeting synuclein-γ. Asian Pac J Cancer Prev. 15:6949–6954.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kastl L, Brown I and Schofield AC:
miRNA-34a is associated with docetaxel resistance in human breast
cancer cells. Breast Cancer Res Treat. 131:445–454. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kent OA and Mendell JT: A small piece in
the cancer puzzle: MicroRNAs as tumor suppressors and oncogenes.
Oncogene. 25:6188–6196. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lagos-Quintana M, Rauhut R, Lendeckel W
and Tuschl T: Identification of novel genes coding for small
expressed RNAs. Science. 294:853–858. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Watson JA, Bryan K, Williams R, Popov S,
Vujanic G, Coulomb A, Boccon-Gibod L, Graf N, Pritchard-Jones K and
O'Sullivan M: miRNA profiles as a predictor of chemoresponsiveness
in Wilms' tumor blastema. PLoS One. 8:e534172013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhu S, Zhang L, Zhao Z, Fu W, Fu K, Liu G
and Jia W: microRNA-92a-3p inhibits the cell proliferation,
migration and invasion of Wilms tumor by targeting NOTCH1. Oncol
Rep. 40:571–578. 2018.PubMed/NCBI
|
|
34
|
Miao Y, Zheng W, Li N, Su Z, Zhao L, Zhou
H and Jia L: MicroRNA-130b targets PTEN to mediate drug resistance
and proliferation of breast cancer cells via the PI3K/Akt signaling
pathway. Sci Rep. 7:419422017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang Q, Zhang B, Sun L, Yan Q, Zhang Y,
Zhang Z, Su Y and Wang C: MicroRNA-130b targets PTEN to induce
resistance to cisplatin in lung cancer cells by activating
Wnt/β-catenin pathway. Cell Biochem Funct. 36:194–202. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lv M, Zhong Z, Chi H, Huang M, Jiang R and
Chen J: Genome-wide screen of miRNAs and targeting mRNAs reveals
the negatively regulatory effect of miR-130b-3p on PTEN by PI3K and
integrin β1 signaling pathways in bladder carcinoma. Int J Mol Sci.
18:782017. View Article : Google Scholar
|
|
37
|
Zhou D, Zhang L, Sun W, Guan W, Lin Q, Ren
W, Zhang J and Xu G: Cytidine monophosphate kinase is inhibited by
the TGF-β signalling pathway through the upregulation of
miR-130b-3p in human epithelial ovarian cancer. Cell Signal.
35:197–207. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yu T, Cao R, Li S, Fu M, Ren L, Chen W,
Zhu H, Zhan Q and Shi R: MiR-130b plays an oncogenic role by
repressing PTEN expression in esophageal squamous cell carcinoma
cells. BMC Cancer. 15:292015. View Article : Google Scholar : PubMed/NCBI
|
